|
Volumn 7, Issue 5, 2003, Pages 535-540
|
Acute myeloid leukemia: a classification and treatment update.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
PROTEIN TYROSINE KINASE;
RETINOID;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGE;
CASE REPORT;
CLASSIFICATION;
DRUG ANTAGONISM;
DRUG RESISTANCE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HOSPITALIZATION;
HUMAN;
IMMUNOTHERAPY;
MALE;
METHODOLOGY;
PATIENT SELECTION;
PROGNOSIS;
REMISSION;
REVIEW;
SALVAGE THERAPY;
ADULT;
AGE FACTORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG RESISTANCE, NEOPLASM;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOTHERAPY;
LEUKEMIA, MYELOCYTIC, ACUTE;
MALE;
PATIENT SELECTION;
PROGNOSIS;
PROTEIN-TYROSINE KINASES;
REMISSION INDUCTION;
RETINOIDS;
SALVAGE THERAPY;
SEVERITY OF ILLNESS INDEX;
|
EID: 0642286445
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/03.CJON.535-540 Document Type: Review |
Times cited : (9)
|
References (40)
|